re: Akebia Therapeutics (AKBA)- Vadadustat FDA Approved AT LAST!!

I sold at 3.53, bought back in at 2.60 and then doubled my position when it hit $2.44.

I hope this thing takes off by year end.

The next drug is their blockbuster.

The current one made 33 million this quarter. Did I read that correctly?

Favorable momentum again.
FDA decision by 29 March 2022 for those interested.

quote:

---

I’ve got a sell at $5. Am I too high?

---

You’re thinking what I’m thinking.

I plan to load up to maybe 1,000 shares below $4.
I’ll probably sell most of them before the fda decision. $5-6 is attainable before then.

Quietly up to 507 shares and adding more tomorrow before earnings. The duration of this accumulation range has been a pleasant surprise. I don't think AKBA will stay below $3 for too much longer, and when it doesn't I think we see 3.50 quickly.

Vadadustat PDUFA is starting to gain steam. It's already approved in Japan with Otsuka partnership.

29 March 2022 reporting date.

Now days I’m buying $6/week, but considering throwing more at it before the big day.

No worries here. Sector dragging it down.

I’m up to about 5000 shares. I think it hits $3 in the next couple of months.

What is it about this time of year that makes biotech shine? I would agree that at least this year the charts are all beat to hell with most biotech stocks, so hopefully they've bottomed out and should be on their way back up.

Good run today. Hopefully this is the start of a trend.

What are your thoughts on the news? I’m assuming there is contingency language in the contract dependent on approval, so does this really change anything? If so, what?